Ligandal

Oakland, United States Founded: 2013 • Age: 13 yrs
Nanoparticle technology for precise gene and CRISPR delivery is developed.

About Ligandal

Ligandal is a company based in Oakland (United States) founded in 2013. Ligandal has raised $64 thousand across 1 funding round. Ligandal operates in a competitive market with competitors including eGenesis, Beam Therapeutics, Korro Bio, Liquidia and Scribe Therapeutics, among others.

  • Headquarter Oakland, United States
  • Sectors
    Healthcare
    Technology
  • Website ligandal.com
Key Metrics
  • Total Equity Funding
    $64K (USD)

    in 1 rounds

  • Latest Funding Round
    $64K (USD), Seed

    Jan 2014

Funding Insights of Ligandal

Ligandal has successfully raised a total of $64K through 1 strategic funding round. The most recent funding activity was a Seed round of $64 thousand completed in January 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $64,000
  • Total Rounds 1
  • Last Round Seed β€” $64,000
  • First Round $64,000

    (Jan 2014)

All 1 funding rounds of Ligandal with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2014$64,000Seed––
–

People of Ligandal

12 people are tracked at Ligandal (6 in leadership, 6 in board & advisors).

NameRoleGroup
Adam Stein
Chief Scientific OfficerLeadership
☤ Bryce Chaney, MBA
Head Of Business DevelopmentLeadership
Daniel B. (Olu) Fagbuyi, M.D.
Chief Medical Officer & Executive Vice President of Business Development & Governmental AffairsLeadership
Diana Douglas
Executive Assistant to the CEOLeadership
Andre Watson
Founder, Chairman & CEOLeadership
Tushar Nuwal
CBO & COOLeadership
Rosemarie Truman
AdvisorBoard & advisors
Agnieszka Czechowicz
AdvisorBoard & advisors
Jeff Karp
AdvisorBoard & advisors
Robert Stroud
AdvisorBoard & advisors
Jack Lewin
AdvisorBoard & advisors
Stephen Delellis
AdvisorBoard & advisors
Premium access

Complete people profiles for Ligandal

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Ligandal

2 dated milestones of Ligandal across 1 years, from founding to its latest funding, stage changes and deals.

  1. Founded Ligandal is founded.
  2. Funding First funding round of $64K.

Competitors of Ligandal

Ligandal operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as eGenesis, Beam Therapeutics, Korro Bio, Liquidia and Scribe Therapeutics, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
egenesisbio.com2015Cambridge, United States$481.42M94
Gene transplantation platform for humanizing pig cells is developed.
beamtx.com2017Cambridge, United States$222M340
Developer of gene therapy using CRISPR base editing to treat diseases
korrobio.com2018Cambridge, United States$4M77
RNA-editing technologies are provided for precision medicine applications.
liquidia.com2004United States$75.3M63
Engineered particles & films for life and material sciences applications
scribetx.com2018Alameda, United States$120M–
A CRISPR-based gene-editing platform is developed for therapeutic applications.
sirnaomics.com2007Gaithersburg, United States$267M88
RNA-based therapeutics for cancer and fibrosis are developed.
tesseratherapeutics.com2017Cambridge, United States$610M149
New genome engineering technology is provided for treating multiple diseases.
locus-bio.com2015Raleigh, United States$67.33M74
Developer of therapeutics for infectious disease and inflammatory indications
metagenomi.co2016Berkeley, United States$376.37M–
Next-generation gene editing tools are developed for drug enhancement.
Premium access

Detailed competitors of Ligandal

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Ligandal

Websites that share an audience with Ligandal (ligandal.com).

Similar websites

Websites whose visitors overlap most with Ligandal. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
bplifescience.com
bplifescience.com
100%
–––
altrubio.com
98%
2.3K#7,696,601View details
mandalmed.com
98%
1.3K#14,142,095View details
corvuspharma.com
97%
13.6K#3,366,661View details
tempobioscience.com
97%
6.1K#3,342,449View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 30 similar websites and full traffic analytics for Ligandal

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 30 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Latest news on Ligandal

Premium access

Complete news archive for Ligandal

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Ligandal

10 companies that operate in the same segment as Ligandal (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Digital sequencing technology for cancer detection is developed.
2012Redwood City, California, United StatesUSD 557.5 MUSD 982.02 M2,020
Circulating tumor DNA is screened for early cancer detection.
2016Menlo Park, California, United StatesUSD 3.22 BUSD 147.17 M1,000
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.3 BUSD 301.49 M1,480
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits
2006Sunnyvale, California, United StatesUSD 943.53 MUSD 189.9 M265
Provider of DNA testing services to create a family tree and ancestor
2003Yehud, Central District, IsraelUSD 40 M––
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M––
Gene therapies for rare diseases including retinal dystrophies are developed.
2013Philadelphia, Pennsylvania, United StatesUSD 82.8 MUSD 64.73 M822
Therapeutics for genetic diseases are developed through targeted interventions.
2015Palo Alto, California, United StatesUSD 434.2 MUSD 502.08 M730
Provider of an online genealogy platform offering a host of services
1996Lehi, Utah, United StatesUSD 146.2 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Ligandal

Ligandal was founded in 2013 and raised its 1st funding round 1 year after it was founded.

Ligandal is headquartered in Oakland, United States. It is registered at Oakland, California, United States.

Ligandal is a funded company, having raised a total of $64K across 1 funding round to date. The company's 1st funding round was a Seed of $64K, raised on Jan 2014.

Ligandal was founded in 2013 and is based in Oakland, United States, operating in the biotechnology sector. Proprietary nanoparticle platforms are developed for targeted delivery of drugs and non-viral genome editing tools, such as CRISPR and TALENs, to specific cells and organelles. Effectiveness has been demonstrated through in vitro and in vivo experiments, supporting applications in biological process control.

Ligandal's top competitors include eGenesis, Tessera Therapeutics and Korro Bio.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available